Qiagen N.V. Common Shares (QGEN)

SG&A Expenses

$586.14M

TTM · Period ending: · USD

QGEN logo

QGEN SG&A Expenses

Latest reported$586.14M
QGEN TTM SG&A Expenses ($5.90M → $586.14M)
High-resolution chart · PNG

QGEN sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Qiagen N.V. Common Shares SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
586,138,000
588,115,000
583,669,000
571,505,000
569,055,000
563,614,000
564,361,000
568,601,000
568,056,000
570,275,000
579,166,000
587,425,000
592,776,000
598,671,000
603,945,000
602,008,000
599,765,000
589,759,000
584,468,000
585,262,000
572,147,000
548,974,000
525,362,000
495,894,000
491,560,000
509,546,000
519,169,000
521,947,000
524,525,000
539,039,000
533,495,000
574,058,000
574,214,000
577,199,000
573,755,000
562,414,000
561,691,000
537,525,000
532,730,000
496,557,000
482,097,000
469,850,000
464,837,000
487,608,000
496,428,000
500,038,000
503,424,000
509,902,000
520,714,000
560,221,000
570,596,000
564,404,000
551,060,000
507,868,000
495,616,000
534,042,000
528,281,000
514,315,000
492,839,000
410,528,000
390,105,000
381,528,000
377,493,000
387,574,000
382,673,000
371,637,000
360,747,000
364,320,000
352,910,000
347,246,000
341,341,000
308,490,000
298,008,000
265,676,000
236,622,000
201,349,000
175,813,000
174,741,000
168,046,000
158,639,000
151,156,000
140,068,000
134,812,000
132,277,000
128,485,000
127,175,000
129,221,000
130,080,000
132,468,000
131,425,000
125,274,000
122,384,000
120,349,000
118,650,000
117,116,000
111,982,000
108,975,000
103,510,000
100,852,000
99,569,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.